Literature DB >> 19287206

Functional diversity of SDF-1 splicing variants.

Miroslaw Janowski1.   

Abstract

SDF-1 is ubiquitously expressed in vertebrate tissues in a constitutive manner. It performs an essential role in cell migration and proliferation as well as participates in tissue-specific physiological processes such as neuromodulation. It is also involved in many pathological processes including: HIV infection, metastatic malignancy, chronic inflammatory disorders and benign proliferative diseases. SDF-1 is mostly regulated at the splicing, and not transcriptional level. Different splicing variants share agonist potency to their cognate receptor, CXCR4, but are characterized by distinct properties. SDF-1alpha is the predominant isoform found in all organs, but undergoes rapid proteolysis in blood. SDF-1beta is more resistant to blood-dependent degradation, stimulates angiogenesis and is present in highly vascularized organs such as: the liver, spleen and kidneys. In contrast, SDF-1gamma is located in very active, less vascularized organs susceptible to infarction such as the heart and the brain. The understanding of the functional diversity of the different splicing variants will help in developing therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287206      PMCID: PMC2712802          DOI: 10.4161/cam.3.3.8260

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  80 in total

1.  Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system.

Authors:  T N Tham; F Lazarini; I A Franceschini; F Lachapelle; A Amara; M Dubois-Dalcq
Journal:  Eur J Neurosci       Date:  2001-03       Impact factor: 3.386

2.  NMR studies of active N-terminal peptides of stromal cell-derived factor-1. Structural basis for receptor binding.

Authors:  E L Elisseeva; C M Slupsky; M P Crump; I Clark-Lewis; B D Sykes
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

3.  Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system.

Authors:  M Gleichmann; C Gillen; M Czardybon; F Bosse; R Greiner-Petter; J Auer; H W Müller
Journal:  Eur J Neurosci       Date:  2000-06       Impact factor: 3.386

4.  CD34+ cell responsiveness to stromal cell-derived factor-1alpha underlies rate of engraftment after peripheral blood stem cell transplantation.

Authors:  Leah A Marquez-Curtis; A Robert Turner; Loree M Larratt; Brenda Letcher; Siow F Lee; Anna Janowska-Wieczorek
Journal:  Transfusion       Date:  2008-10-02       Impact factor: 3.157

Review 5.  Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.

Authors:  Takuji Iwamoto; Hiroshi Okamoto; Yoshiaki Toyama; Shigeki Momohara
Journal:  FEBS J       Date:  2008-07-24       Impact factor: 5.542

6.  Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1alpha: another player in hematopoietic stem/progenitor cell mobilization?

Authors:  Leah Marquez-Curtis; Ali Jalili; Kathleen Deiteren; Neeta Shirvaikar; Anne-Marie Lambeir; Anna Janowska-Wieczorek
Journal:  Stem Cells       Date:  2008-02-21       Impact factor: 6.277

Review 7.  Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.

Authors:  Geoffrey L Uy; Michael P Rettig; Amanda F Cashen
Journal:  Expert Opin Biol Ther       Date:  2008-11       Impact factor: 4.388

8.  Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.

Authors:  Bokyung Sung; Sonia Jhurani; Kwang Seok Ahn; Yoichi Mastuo; Tingfang Yi; Sushovan Guha; Mingyao Liu; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

9.  Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.

Authors:  Sakae Mikami; Hiroshi Nakase; Shuji Yamamoto; Yasuhiro Takeda; Takuya Yoshino; Katushiro Kasahara; Satoru Ueno; Norimitsu Uza; Shinya Oishi; Nobutaka Fujii; Takashi Nagasawa; Tsutomu Chiba
Journal:  J Pharmacol Exp Ther       Date:  2008-08-20       Impact factor: 4.030

10.  SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum.

Authors:  C Limatola; A Giovannelli; L Maggi; D Ragozzino; L Castellani; M T Ciotti; F Vacca; D Mercanti; A Santoni; F Eusebi
Journal:  Eur J Neurosci       Date:  2000-07       Impact factor: 3.386

View more
  41 in total

Review 1.  Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells.

Authors:  Aysegul Ocal Sahin; Miranda Buitenhuis
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

2.  Myocardial Ischemia Induces SDF-1α Release in Cardiac Surgery Patients.

Authors:  Bong-Sung Kim; Denise Jacobs; Christoph Emontzpohl; Andreas Goetzenich; Josefin Soppert; Mareike Jarchow; Lisa Schindler; Luisa Averdunk; Sandra Kraemer; Gernot Marx; Jürgen Bernhagen; Norbert Pallua; Heinz-Peter Schlemmer; David Simons; Christian Stoppe
Journal:  J Cardiovasc Transl Res       Date:  2016-04-07       Impact factor: 4.132

3.  CXCL12-mediated murine neural progenitor cell movement requires PI3Kβ activation.

Authors:  Borja L Holgado; Laura Martínez-Muñoz; Juan Antonio Sánchez-Alcañiz; Pilar Lucas; Vicente Pérez-García; Gema Pérez; José Miguel Rodríguez-Frade; Marta Nieto; Oscar Marín; Yolanda R Carrasco; Ana C Carrera; Manuel Alvarez-Dolado; Mario Mellado
Journal:  Mol Neurobiol       Date:  2013-04-19       Impact factor: 5.590

4.  The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing.

Authors:  Jun Ishihara; Ako Ishihara; Richard D Starke; Claire R Peghaire; Koval E Smith; Thomas A J McKinnon; Yoji Tabata; Koichi Sasaki; Michael J V White; Kazuto Fukunaga; Mike A Laffan; Matthias P Lutolf; Anna M Randi; Jeffrey A Hubbell
Journal:  Blood       Date:  2019-04-11       Impact factor: 22.113

5.  Glial cells activation potentially contributes to the upregulation of stromal cell-derived factor-1α after optic nerve crush in rats.

Authors:  Xi-Tao Yang; Dong-Chao Pan; Er-Tao Chen; Yong-Yan Bi; Dong-Fu Feng
Journal:  Neurochem Res       Date:  2013-07-06       Impact factor: 3.996

6.  The role of SDF-1α/Rac pathway in the regulation of endothelial progenitor cell polarity; homing and expression of Rac1, Rac2 during endothelial repair.

Authors:  Li Shen; Yongxing Gao; Juying Qian; Yizhe Wu; Mingming Zhou; Aijun Sun; Yunzeng Zou; Junbo Ge
Journal:  Mol Cell Biochem       Date:  2011-10-02       Impact factor: 3.396

Review 7.  CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.

Authors:  Xueqing Sun; Guangcun Cheng; Mingang Hao; Jianghua Zheng; Xiaoming Zhou; Jian Zhang; Russell S Taichman; Kenneth J Pienta; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

8.  Release of matrix metalloproteinase-8 during physiological trafficking and induced mobilization of human hematopoietic stem cells.

Authors:  Carolin Steinl; Mike Essl; Thomas D Schreiber; Konstanze Geiger; Lea Prokop; Stefan Stevanović; Oliver Pötz; Harald Abele; Johannes T Wessels; Wilhelm K Aicher; Gerd Klein
Journal:  Stem Cells Dev       Date:  2013-02-12       Impact factor: 3.272

9.  Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues.

Authors:  Risala Hussain Allami; Claudine Graf; Ksenia Martchenko; Beatrice Voss; Marc Becker; Martin R Berger; Peter R Galle; Matthias Theobald; Thomas C Wehler; Carl C Schimanski
Journal:  Oncol Lett       Date:  2016-01-25       Impact factor: 2.967

10.  Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor.

Authors:  Michael Gorelik; Inema Orukari; Joanne Wang; Shashikala Galpoththawela; Heechul Kim; Michael Levy; Assaf A Gilad; Amnon Bar-Shir; Douglas A Kerr; Andre Levchenko; Jeff W M Bulte; Piotr Walczak
Journal:  Radiology       Date:  2012-08-24       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.